NCT00003974View on ClinicalTrials.gov

Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage IIIA Non-small Cell Lung Cancer or With Stage I or Stage II Mesothelioma

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 31, 1997

Primary Completion Date

June 30, 1998

Study Completion Date

November 30, 2000

Conditions
Lung CancerMalignant Mesothelioma
Interventions
BIOLOGICAL

lung tumor associated antigen

DRUG

DetoxPC

DRUG

chemotherapy

DRUG

cyclophosphamide

Trial Locations (1)

14263-0001

Roswell Park Cancer Institute, Buffalo

All Listed Sponsors
lead

Roswell Park Cancer Institute

OTHER